A novel cisplatin mediated apoptosis pathway is associated with acid sphingomyelinase and FAS proapoptotic protein activation in ovarian cancer
- 7 April 2015
- journal article
- research article
- Published by Springer Nature in Apoptosis
- Vol. 20 (7) , 960-974
Abstract
Platinum-based anticancer drugs, including cisplatin and carboplatin, have been cornerstones in the treatment of solid tumors. We report here that these DNA-damaging agents, particularly cisplatin, induce apoptosis through plasma membrane disruption, triggering FAS death receptor via mitochondrial (intrinsic) pathways. Our objectives were to: quantify the composition of membrane metabolites; and determine the potential involvement of acid sphingomyelinase (ASMase) in the FAS-mediated apoptosis in ovarian cancer after cisplatin treatment. The resulting analysis revealed enhanced apoptosis as measured by: increased phosphocholine, and glycerophosphocholine; elevated cellular energetics; and phosphocreatine and nucleoside triphosphate concentrations. The plasma membrane alterations were accompanied by increased ASMase activity, leading to the upregulation of FAS, FASL and related pro-apoptotic BAX and PUMA genes. Moreover FAS, FASL, BAX, PUMA, CASPASE-3 and -9 proteins were upregulated. Our findings implicate ASMase activity and the intrinsic pathways in cisplatin-mediated membrane demise, and contribute to our understanding of the mechanisms by which ovarian tumors may become resistant to cisplatin.Keywords
This publication has 55 references indexed in Scilit:
- Acid sphingomyelinase, cell membranes and human disease: Lessons from Niemann–Pick diseaseFEBS Letters, 2009
- Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluationJournal of Ovarian Research, 2009
- Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathwayJournal of Cell Biology, 2008
- Contribution of membrane localization to the apoptotic activity of PUMAApoptosis, 2007
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Genome-Wide Requirements for Resistance to Functionally Distinct DNA-Damaging AgentsPLOS Genetics, 2005
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Control of apoptosis by the cellular ATP levelFEBS Letters, 1996
- Preferential binding of cisplatin to mitochondrial DNA of Chinese hamster ovary cellsMutation Research Letters, 1995
- The role of endogenous phosphatidylcholine and ceramide in the biosynthesis of sphingomyelin in mouse fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982